Compared with healthy subjects, AML patients had abnormal NK cell populations in the peripheral blood (PB) and bone marrow (BM), which showed an increased frequency of TIGIT+, PVRIG+, CD39+, and CD69+NK cells. The gene discussed is ENTPD1; the disease is acute myeloid leukemia.